Literature DB >> 2121629

Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients.

S K Chambers1, J T Chambers, C Holm, R E Peschel, P E Schwartz.   

Abstract

The sequelae of lateral ovarian transposition (LOT) in cervical cancer patients has been examined only in the light of the effect of pelvic radiation therapy on ovarian preservation. Preservation of ovarian function has not been examined in the absence of radiation therapy, and symptomatic ovarian cyst formation in transposed ovaries with the need for subsequent surgery has not been addressed in either radiated or unirradiated cervical cancer patients. We studied 84 premenopausal FIGO stage IA or IB cervical cancer patients treated by primary radical hysterectomy between the years 1978 and 1988. None of these patients received adjuvant radiation therapy. Fifty-nine of eight-four patients had radical hysterectomy (RH) without LOT. These patients were compared to 25 of 84 patients who had LOT in addition to RH. The incidence of symptomatic ovarian cysts, the majority requiring operative intervention, was 24% in the ovarian transposition patients as compared to 7.4% in those who had RH alone. This threefold increase in symptomatic benign ovarian cyst formation in the translocated ovary was significant (P = .048). On the other hand, LOT in these RH patients does not appear to increase the incidence of early menopause (P greater than 0.05). On follow-up of those patients who did not incur additional surgery or radiation, 4.3% became menopausal, as compared to 4.1% of those patients undergoing RH alone, with the mean ages of the two groups being comparable.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121629     DOI: 10.1016/0090-8258(90)90424-j

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

Review 1.  Fertility preservation in women with malignant tumors and gonadotoxic treatments.

Authors:  Michael von Wolff; Darius Dian
Journal:  Dtsch Arztebl Int       Date:  2012-03-23       Impact factor: 5.594

Review 2.  [Radiation reactions in the gonads: importance in patient counseling].

Authors:  T Herrmann
Journal:  Strahlenther Onkol       Date:  1997-10       Impact factor: 3.621

3.  Ovarian transposition before radiotherapy in cervical cancer patients: functional outcome and the adequate dose constraint.

Authors:  Lina Yin; Saiquan Lu; Jun Zhu; Weiling Zhang; Guihao Ke
Journal:  Radiat Oncol       Date:  2019-06-10       Impact factor: 3.481

4.  Ovarian Transposition Before Pelvic Radiation Therapy: Spatial Distribution and Dose Volume Analysis.

Authors:  Christopher Gay; Yaniv R Raphael; Jennifer Steers; Diana J Lu; John H Lewis; John DeMarco; Benedick Fraass; Bobbie J Rimel; Roja Zakariaee; Mitchell Kamrava; Katelyn M Atkins
Journal:  Adv Radiat Oncol       Date:  2021-10-24

5.  Ovarian Function Preservation in Patients With Cervical Cancer Undergoing Hysterectomy and Ovarian Transposition Before Pelvic Radiotherapy.

Authors:  Wonguen Jung; Yun H Kim; Kyung S Kim
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

6.  Outcomes of ovarian transposition in cervical cancer; an updated meta-analysis.

Authors:  Alexandros Laios; Mohamed Otify; Argyro Papadopoulou; Ioannis D Gallos; Thomas Ind
Journal:  BMC Womens Health       Date:  2022-07-22       Impact factor: 2.742

7.  Laparoscopic ovarian transposition before pelvic radiation in rectal cancer patient: safety and feasibility.

Authors:  Sami Al-Asari; Alaa Abduljabbar
Journal:  Ann Surg Innov Res       Date:  2012-09-17

Review 8.  Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis.

Authors:  Kumar Gubbala; Alex Laios; Ioannis Gallos; Pubudu Pathiraja; Krishnayan Haldar; Thomas Ind
Journal:  J Ovarian Res       Date:  2014-06-25       Impact factor: 4.234

9.  Laparoscopic Ovarian Transposition and Ovariopexy for Fertility Preservation in Patients Treated with Pelvic Radiotherapy with or without Chemotherapy.

Authors:  L Turkgeldi; A Cutner; E Turkgeldi; A Al Chami; A Cassoni; N Macdonald; T Mould; A Nichol; A Olaitan; E Saridogan
Journal:  Facts Views Vis Obgyn       Date:  2019-09

10.  Dosimetric evaluation of ovaries and pelvic bones associated with clinical outcomes in patients receiving total body irradiation with ovarian shielding.

Authors:  Keiko Akahane; Katsuyuki Shirai; Masaru Wakatsuki; Masato Suzuki; Shogo Hatanaka; Yuta Takahashi; Masahiro Kawahara; Kazunari Ogawa; Satoru Takahashi; Noriko Oyama-Manabe; Masahiro Ashizawa; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  J Radiat Res       Date:  2021-09-13       Impact factor: 2.724

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.